NCT04708054 2026-02-19Venetoclax to Improve Outcomes of Fractionated Busulfan Regimen in Patients With High-Risk AML and MDSM.D. Anderson Cancer CenterPhase 2/3 Recruiting324 enrolled
NCT06001385 2026-02-05OPTIMIZECenter for International Blood and Marrow Transplant ResearchPhase 2 Active not recruiting313 enrolled
NCT03613532 2025-12-24Venetoclax Added to Fludarabine + Busulfan Prior to Transplant and to Maintenance Therapy for AML, MDS, and MDS/MPNDana-Farber Cancer InstitutePhase 1 Active not recruiting102 enrolled